Home - Products - Others - Other Targets - sHNG, [Gly14] - HN, [Gly14] – Humanin

sHNG, [Gly14] - HN, [Gly14] – Humanin

CAS No. 330936-70-4

sHNG, [Gly14] - HN, [Gly14] – Humanin( ——— )

Catalog No. M41854 CAS No. 330936-70-4

(Gly14)-Humanin (human) (14-Glycine-Humanin (human)) is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) has anti-apoptotic and neuroprotective functions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    sHNG, [Gly14] - HN, [Gly14] – Humanin
  • Note
    Research use only, not for human use.
  • Brief Description
    (Gly14)-Humanin (human) (14-Glycine-Humanin (human)) is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) has anti-apoptotic and neuroprotective functions.
  • Description
    (Gly14)-Humanin (human) (14-Glycine-Humanin (human)) is an analog of Humanin in which the 14th amino acid serine was replaced with glycine (Gly). (Gly14)-Humanin (human) has anti-apoptotic and neuroprotective functions.
  • In Vitro
    Cell Viability Assay Cell Line:Human umbilical vein endothelial cells (HUVECs),Concentration:100 nM, 1 μM and 10 μM Incubation Time:Pretreatment 3 hours and then treated with 72 hours Result:Significantly increased cell viability.Western Blot Analysis Cell Line:Human umbilical vein endothelial cells (HUVECs),Concentration:1 μM Incubation Time:Pretreatment 3 hours and then treated with 72 hours Result:Reduced the ratio of bax/bcl-2.
  • In Vivo
    Animal Model:Adult male CD-1 mice (25-30 g; 10-12-week-old) bearing traumatic brain injury (TBI) Dosage:0.1 μg/5 μL Administration:Intracerebroventricularly (i.c.v.); once Result:Decreased cells with plasmalemma permeability in the injured cortex and hippocampus, reduced brain lesion volume, improved motor performance.
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    330936-70-4
  • Formula Weight
    2657.25
  • Molecular Formula
    C118H202N34O31S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ying Xie, et al. Protection effect of Gly14-Humanin from apoptosis induced by high glucose in human umbilical vein endothelial cells. Diabetes Res Clin Pract. 2014 Dec;106(3):560-6. ?
molnova catalog
related products
  • IMSs inhibitor S12 P...

    IMSs inhibitor S12 Perchlorate has antifibrotic and anticancer properties.

  • Ontuxizumab

    Ontuxizumab (MORAb-004) is a potent IgG1/κ monoclonal antibody targeting endomelanic acid with anti-tumor effects.

  • Ingenol

    Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.